MTX-Sparing in myasthenia gravis. 18-mo OL RCT of MTX vs PBO in 35 recently Dx, pred Rx MG pts (MGFA Class II/III) showed @ 18 mos MTX reduced Pred use (5,663 vs 6,684 mg total), w/ shorter pred reduction times and less daily dose mos 6, 9–18 https://t.co/8t2sJMwBnx https://t.co/3G0wd1FQ2s